Kevin E Carroll
Savonix, USA
Posters & Accepted Abstracts: Surgery
Dementia rates in Japan are expected to dramatically increase to 7.3 million people by 2025, early identification of those with dementia will be crucial. This presentation will discuss how recent innovations in digital mobile technology have advanced to the point in which accurate and low-cost baseline cognitive screening should become the standard of practice for all people over the age of 65. Baseline cognitive screening will allow for faster and more accurate assessment, diagnosis, and treatment when a suspected cognitive change has occurred, potentially reversing and or retarding the advancement of dementia. Early identification will lead to better control and management of medical, emotional, and behavioral issues and will also lead to earlier medication treatment, at the stage when these medications are most likely to help. Similar to the positive impact that cancer screening has led to much earlier and successful diagnoses and treatments, we believe that the same push to screen for dementia will also have a comparable positive effect. This presentation will discuss how to use the Savonix mobile app to assess baseline cognition will streamline assessment time and improve accuracy of estimating cognitive changes. We propose that acquiring baseline cognitive data will lead to more efficient use of fiduciary resources and neuropsychologistâ??s time as well as expedite treatment. Baseline assessments will also lead to earlier diagnoses with more efficient management of comorbid conditions, early financial and medical planning, and accelerated entry into clinical research.
E-mail: kcarroll@savonix.com
Journal of Surgery received 288 citations as per Google Scholar report